Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiotherapy quality assurance in the PRO-GLIO trial: results from a dummy run comparing experts across twelve institutions in two Scandinavian countries.

Clinical and translational radiation oncology·2026
Same author

Spatial-temporal recurrence patterns of grade 4 glioma using deep learning integrated multiparametric MRI and molecular pathology.

NPJ precision oncology·2026
Same author

Educational interventions for training oncology residents in palliative medicine: a rapid review of the available evidence to inform training standards in cancer care.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Embedding nutrition into routine oncology care: about time?

Oncology reviews·2026
Same author

Norwegian consensus guidelines for selection of neuro-oncology patients to proton therapy.

Clinical and translational radiation oncology·2026
Same author

EU Joint Action: Integrating Palliative Care in the EU Cancer Agenda: Insights From JANE-2.

Journal of pain and symptom management·2026
Same journal

Cortical and brainstem mechanisms of pain: linking defensive responses, descending modulation, and affective-sensory integration.

Current opinion in supportive and palliative care·2026
Same journal

Comparison of the EORTC QLQ-EN24, FACT-En, and FEnSI-23 for assessing quality of life in endometrial cancer: a systematic review.

Current opinion in supportive and palliative care·2026
Same journal

Dysphagia, aspiration, and respiratory problems in people with chronic respiratory illness.

Current opinion in supportive and palliative care·2026
Same journal

Decision-making and treatment planning for older adults with pre-existing cognitive impairment and cancer.

Current opinion in supportive and palliative care·2026
Same journal

Clinical decision support system for breathlessness.

Current opinion in supportive and palliative care·2026
Same journal

The prevalence of persisting breathlessness despite treatment in chronic conditions.

Current opinion in supportive and palliative care·2026
See all related articles

Related Experiment Video

Updated: May 17, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

Evidence base for multimodal therapy in cachexia.

Tora S Solheim1, Barry J A Laird

  • 1Department of Cancer Research and Molecular Medicine, European Palliative Care Research Centre, Norwegian University of Science and Technology, Trondheim, Norway. tora.l.skeidsvoll@ntnu.no

Current Opinion in Supportive and Palliative Care
|November 1, 2012
PubMed
Summary
This summary is machine-generated.

Multimodal treatment shows promise for cancer cachexia management. Combining exercise, nutrition, symptom control, and medication may offer the best approach for this complex condition.

Related Experiment Videos

Last Updated: May 17, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

Area of Science:

  • Oncology
  • Metabolism
  • Nutrition Science

Background:

  • Cancer cachexia is a complex multifactorial condition.
  • Unimodal treatment strategies have shown limited success in managing cachexia.
  • Growing evidence suggests a multimodal approach is necessary for effective intervention.

Purpose of the Study:

  • To review the existing evidence for multimodal treatment strategies in cancer cachexia.
  • To evaluate the efficacy of combining different therapeutic modalities for cancer cachexia.

Main Methods:

  • Literature review of studies investigating multimodal interventions for cancer cachexia.
  • Analysis of treatment outcomes in studies combining exercise, nutrition, symptom management, and pharmacotherapy.

Main Results:

  • Some studies indicate significant positive effects of multimodal treatment on cachexia outcomes.
  • Currently, no randomized controlled trials fully integrate structured exercise, nutrition, symptom management, and drug treatment.
  • Altered metabolism in cancer cachexia requires a comprehensive therapeutic strategy.

Conclusions:

  • The efficacy of drug interventions for cancer cachexia is likely maximized within a multimodal treatment framework.
  • Future clinical trials should target patients in earlier stages of cachexia.
  • Validated outcome measures are crucial for future cachexia research.